Efficacy, Safety, and Economics of Intravenous Levetiracetam for Status Epilepticus: A Systematic Review and Meta-Analysis by Zhan-Miao Yi, Zhan-Miao Yi, Zhan-Miao Yi, Xu-Li Zhong, Ming-Lu Wang, Ming-Lu Wang, Yuan Zhang, Suo-Di Zhai, Suo-Di Zhai

Connect to this object online.

The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis by Ruilin Wang, Ruilin Wang, Xinya Li, Xinya Li, Xinya Li, Xinya Li, Xinchun Gu, Qian Cai, Yayong Wang, Zhan-Miao Yi, Zhan-Miao Yi, Zhan-Miao Yi, Li-Chia Chen

Connect to this object online.

Impact of a Collaborative Pharmaceutical Care Service for Patients With Parkinson's Disease by Zhan-Miao Yi, Zhan-Miao Yi, Sarah Willis, Yuan Zhang, Na Liu, Qi-Yu Tang, Qi-Yu Tang, Suo-Di Zhai, Suo-Di Zhai

Connect to this object online.

Mapping Evidence of Pharmacy Services for COVID-19 in China by Zhan-Miao Yi, Zhan-Miao Yi, Zhan-Miao Yi, Yang Hu, Yang Hu, Yang Hu, Yang Hu, Guan-Ru Wang, Guan-Ru Wang, Guan-Ru Wang, Guan-Ru Wang, Rong-Sheng Zhao, Rong-Sheng Zhao, Rong-Sheng Zhao

Connect to this object online.

Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study by Emilie Clay, Junwen Zhou, Zhan-Miao Yi, Suodi Zhai, Mondher Toumi

Connect to this object online.